1
项与 AAV1-gamma-sarcoglycan vector(Viromed, Inc.) 相关的临床试验Phase I Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
The purpose of this trial is to study the evaluation of clinical safety and feasibility of gene therapy in patients with limb girdle muscular dystrophy type 2C (gamma-sarcoglycanopathy).
100 项与 AAV1-gamma-sarcoglycan vector(Viromed, Inc.) 相关的临床结果
100 项与 AAV1-gamma-sarcoglycan vector(Viromed, Inc.) 相关的转化医学
100 项与 AAV1-gamma-sarcoglycan vector(Viromed, Inc.) 相关的专利(医药)
100 项与 AAV1-gamma-sarcoglycan vector(Viromed, Inc.) 相关的药物交易